Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Luban

Showing results (21-30 of 152) with videos related to

Pageof 16
Sort By:
Retrovirology|June 24, 2011
Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferonThomas Pertel, Christian Reinhard, Jeremy Luban
Viruses|November 27, 2024
piRNA Defense Against Endogenous RetrovirusesMilky Abajorga, Leonid Yurkovetskiy, Jeremy Luban
Journal of Virology|December 23, 2004
Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1Cagan Gurer, Lionel Berthoux, Jeremy Luban
Molecular and Cellular Biology|September 21, 2002
Cyclophilin A peptidyl-prolyl isomerase activity promotes ZPR1 nuclear exportHusam Ansari, Giampaolo Greco, Jeremy Luban
Journal of Virology|January 28, 2006
Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent mannerSarah Sebastian, Elena Sokolskaja, Jeremy Luban
Retrovirology|December 21, 2012
HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotencyFederico A Santoni, Jessica Guerra, Jeremy Luban
BMC Medicine|September 18, 2009
Human cellular restriction factors that target HIV-1 replicationKlaus Strebel, Jeremy Luban, Kuan-Teh Jeang
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2013
The fate of HIV-1 capsid: a biochemical assay for HIV-1 uncoatingYang Yang, Jeremy Luban, Felipe Diaz-Griffero
Journal of Virology|November 16, 2004
Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivityElena Sokolskaja, David M Sayah, Jeremy Luban
Plos Computational Biology|December 3, 2010
Deciphering the code for retroviral integration target site selectionFederico Andrea Santoni, Oliver Hartley, Jeremy Luban
Pageof 16

Showing results (21-30 of 152) with videos related to

Sort By:
Pageof 16
Retrovirology|June 24, 2011
Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferonThomas Pertel, Christian Reinhard, Jeremy Luban
Viruses|November 27, 2024
piRNA Defense Against Endogenous RetrovirusesMilky Abajorga, Leonid Yurkovetskiy, Jeremy Luban
Journal of Virology|December 23, 2004
Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1Cagan Gurer, Lionel Berthoux, Jeremy Luban
Molecular and Cellular Biology|September 21, 2002
Cyclophilin A peptidyl-prolyl isomerase activity promotes ZPR1 nuclear exportHusam Ansari, Giampaolo Greco, Jeremy Luban
Journal of Virology|January 28, 2006
Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent mannerSarah Sebastian, Elena Sokolskaja, Jeremy Luban
Retrovirology|December 21, 2012
HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotencyFederico A Santoni, Jessica Guerra, Jeremy Luban
BMC Medicine|September 18, 2009
Human cellular restriction factors that target HIV-1 replicationKlaus Strebel, Jeremy Luban, Kuan-Teh Jeang
Methods in Molecular Biology (Clifton, N.J.)|October 26, 2013
The fate of HIV-1 capsid: a biochemical assay for HIV-1 uncoatingYang Yang, Jeremy Luban, Felipe Diaz-Griffero
Journal of Virology|November 16, 2004
Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivityElena Sokolskaja, David M Sayah, Jeremy Luban
Plos Computational Biology|December 3, 2010
Deciphering the code for retroviral integration target site selectionFederico Andrea Santoni, Oliver Hartley, Jeremy Luban
Pageof 16